This bill prohibits pharmacy benefits managers from engaging in specific deceptive trade practices, such as hidden payment reductions, steering patients toward affiliated pharmacies, or using patient data to gain economic control over pharmacies. It directly affects pharmacy benefits managers, pharmacists, pharmacies, and healthcare enrollees by defining and banning actions like spread pricing, unfair inducements, and restrictive refill policies for maintenance medications. The legislation also forbids PBMs from exploiting prescription data for marketing or repackaging drugs to extract price markups without informing patients. Violations of these rules are classified as unfair competition, and each individual transaction involving a prohibited act is considered a separate offense.
Establishes a state-run prescription drug purchasing pool, available for participation by nonstate public employers, private employers, and health insurance carriers, to maximize the value of drug discounts available to participants.
This Senate resolution officially designates May 28, 2026, as "Pharmacy Advocacy Day" throughout Rhode Island. The measure recognizes the vital contributions of pharmacists, pharmacy technicians, and student pharmacists to patient care and public health within the state. By declaring this specific date, the resolution encourages citizens and healthcare organizations to participate in events that highlight the role of pharmacy professionals in shaping healthcare policy. Additionally, the Secretary of State is instructed to send certified copies of the resolution to the Rhode Island Pharmacists Association and the Rhode Island Board of Pharmacy.
This bill strengthens oversight of pharmacy benefits managers and pharmacy benefit management services in Rhode Island by requiring them to register with the Department of Business Regulation and file detailed public reports on their financial arrangements and corporate relationships. It mandates that these managers cannot stop pharmacists from telling patients about drug costs or alternative purchasing options, and it prohibits charging copayments that exceed the actual amount the pharmacy receives for dispensing a prescription. Additionally, the law requires a streamlined appeal process for pharmacies to resolve disputes over multi-source generic drug pricing within fifteen days. These changes aim to increase transparency and ensure fair competition in how prescription drug benefits are administered.
Strengthens enforcement of the state's pharmacy audit law by clarifying and tightening audit procedures to ensure pharmacy audits are conducted fairly and transparently.
This bill designates May 28, 2026, as Pharmacy Advocacy Day in Rhode Island to honor the contributions of pharmacists, pharmacy technicians, and student pharmacists to public health. The resolution encourages citizens, healthcare professionals, and organizations to participate in events that promote pharmacy advocacy and raise awareness about the vital role pharmacists play in medication management and patient care. Additionally, the bill directs the Secretary of State to send certified copies of the resolution to the Rhode Island Pharmacists Association and the Rhode Island Board of Pharmacy.
Requires pharmacy benefit managers to apply for certificate of authority from DBR to operate such a business in this state. Empowers the health insurance commissioner to oversee pharmacy benefit managers and penalize violations.
Establishes a state-run prescription drug purchasing pool, available for participation by nonstate public employers, private employers, and health insurance carriers, to maximize the value of drug discounts available to participants.
Strengthens enforcement of the state's pharmacy audit law by clarifying and tightening audit procedures to ensure pharmacy audits are conducted fairly and transparently.
Caps amount payable for 30 day supply of equipment/supplies for insulin administration/glucose monitoring at $25 or equipment designed to last more than 30 days with no deductible commencing January 1, 2027.